You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Actuated Low Stress Endotracheal Tube Cleaner to Improve Neonate Lung Function

    SBC: ACTUATED MEDICAL, INC.            Topic: NICHD

    DESCRIPTION provided by applicant This Phase II SBIR finalizes development and clinically tests Neo ET Clear an Actuated Low Stress Endotracheal Tube ETT Cleaner to Improve Neonate Lung Function Neo ET Clear suctions mucus from mm diameter neonatal endotracheal tubes with significantly reduced deleterious impact on lung function and mechanics as compared to current methods includin ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Advancement to Clinical Candidate of Novel, Potent and Selective Chikungunya virus inhibitor series

    SBC: VENATORX PHARMACEUTICALS INC            Topic: NIAID

    DESCRIPTIONprovided by applicantNovel therapies for the treatment of Chikungunya virusCHIKVinfections are urgently needed to address the alarming spread of this pathogen across the AmericasWe have identified a series of potentselectiveand orally bioavailable inhibitors of CHIKV replicationIn this Direct to Phaseprojectwe will optimize this series of CHIKV inhibitors to Pre Development stage and ad ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. A mechanism based computational tool to optimize pulmonary drug delivery

    SBC: CFD RESEARCH CORPORATION            Topic: 300

    DESCRIPTION provided by applicant Pulmonary drug delivery has emerged as a noninvasive alternative route for the treatment of lung diseases asthma COPD CF and lung cancer In order to obtain the desired level of effectiveness and safety of the inhaled drugs an appropriate deposition on the targeted region and subsequent absorption in the targeted region is vital Multiscale multidisciplin ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  4. An Acoustofluidic Device for Point of Care Sputum Processing and Analysis

    SBC: Ascent Bio-Nano Technologies Inc            Topic: NHLBI

    Project Summary Asthma is a chronic lung disease that causes the airways in the lungs to become inflamed making it difficult to breathe and leading to episodes of intense coughing and wheezing The prevalence of asthma has increased rapidly over the past several decades and more than in Americans are now living with the disease While there is no cure for asthma the symptoms of the disease ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  5. A New Technique for Diabetic Foot Ulcers

    SBC: Noveratech L.L.C.            Topic: 200

    ABSTRACT Diabetes is the leading cause of nontraumatic lower extremity amputations in the United States Diabetic foot ulcers DFUs are responsible for more hospitalizations than any other diabetic complications Currently even the best available treatments achieve only a healing rate for these wounds and this healing is often only temporary with a chance of recurring Our company has ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. A Next Generation, Low Cost Tracking System for Healthcare

    SBC: Q-Track Corporation            Topic: 600

    DESCRIPTION provided by applicant The goal of the Phase I study is to determine the feasibility of piloting a low cost Real Time Location System RTLS for use in healthcare based on a novel technology known as Near Field Electromagnetic The proposed QHealth system promises to support a number of healthcare applications such as equipment management workflow optimization hand hygiene complian ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. An Innovative Device Integrating Cryopreservation, Storage, and Artificial Insemination of Mouse Sperm

    SBC: PARATECHS CORP            Topic: 100

    DESCRIPTION provided by applicant ParaTechs Corporation aims to provide researchers with advanced technology and methods to simplify procedures for laboratory animal models While actively supporting efforts to `reduce replace and refineandapos animal use ParaTechs provides safe and efficient alternatives for surgical procedures We have already brought to market a nonsurgical embryo transfe ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. AN OPEN WEB SERVICE FOR FRAGMENT-BASED DESIGN OF SMALL MOLECULE INHIBITORS

    SBC: CONIFER POINT PHARMACEUTICALS LLC            Topic: 400

    DESCRIPTION provided by applicant Maps of where small chemical fragments bind to proteins are proving to be an important source of information for life sciences research most particularly in drug discovery For example such maps are used to discover binding andquot hot spotsandquot by fragment clustering identify how fragment binding patterns differ among protein structure variatio ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction

    SBC: ENDOPROTECH, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant According to the CDC in ischemic heart disease is the leading cause of death worldwide and in the US approximately patients died of ischemic heart disease It is well established in clinical practice that recanalization of he infarct related artery IRA using percutaneous coronary intervention PCI enhances myocardial salvage and outcomes in pa ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. A novel mechanism based therapy for cystic fibrosis

    SBC: PROGENRA INC            Topic: NHLBI

    Approximately individuals worldwide suffer from cystic fibrosis CF a debilitating ion transport disease characterized by abnormal mucus secretion primarily involving the lungs Following years of symptom management as the only treatment option Kalydeco ivacaftor or VX and Orkambi a combination of ivacaftor plus lumacaftor VX were approved by the FDA to treat the underlyi ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government